Physiomics Plc announce that it has been awarded its first contract with a new UK-based biotech client. The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 GBX | +3.70% |
|
+7.69% | -12.50% |
08:48pm | EARNINGS AND TRADING: Sound Energy sells part of Moroccan assets | AN |
06-13 | Physiomics Secures Virtual Tumor Platform Contract | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.50% | 2.33M | |
-1.39% | 137B | |
+18.54% | 75.73B | |
+18.65% | 39.06B | |
-15.05% | 38.37B | |
-2.30% | 30.31B | |
+4.48% | 14.34B | |
+8.53% | 10.61B | |
-22.99% | 4.06B | |
-41.58% | 3.57B |
- Stock Market
- Equities
- PYC Stock
- News Physiomics Plc
- Physiomics plc Wins Further Contract by Uk-Based Biotech Client